| Name | Title | Contact Details |
|---|---|---|
Maria Latushkin |
Chief Technology Officer | Profile |
William Dougherty |
Vice President of Information Technology and Security | Profile |
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
E*Health Line.com, Inc. is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Palo Alto Research Center is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lake County Tribal Health Consortium is a Lakeport, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Honor provides personalized home care for people who want to continue to live in the homes they love—safely and happily—as they age.